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Background: Previous studies have demonstrated that the consumption of green tea inhibits the growth of
various cancers. Most cancers are believed to be initiated from and maintained by a small population of cancer
stem-like cells (CSC) or tumor-initiating cells (TIC) that are responsible for tumor relapse and chemotherapeutic
resistance. Although epigallocathechin gallate (EGCG), the most abundant catechin in green tea, has been reported
to induce growth inhibition and apoptosis in some cancer cells, its effect on CSC is undefined. In this study,
we enriched CSC by the sphere formation, and provided an efficient model for further experiments. Using this
method, we examined the effects of EGCG regulating the nasopharyngeal carcinoma (NPC) CSC and attempted to
elucidate the possible mechanisms.
Methods: NPC TW01 and TW06 cell lines were enriched by sphere formation and characterized their phenotypical
properties, such as invasion capacity, epithelial-mesenchymal transition (EMT) and gene expression were analyzed
by quantitative real-time reverse transcription polymerase chain reaction (q-RT-PCR). EGCG-induced growth
inhibition in the parental and sphere-derived cells was determined by MTT and bromodeoxyuridine (BrdU) assay.
EGCG-induced apoptosis was analyzed by flow cytometry with Annexin V and PI staining. The effects of EGCG on
sphere-derived cell tumorigenicity, migration and invasion were determined by soft agar assay, wound healing, and
cell invasion assay. The alternation of protein expression regulated by EGCG on these sphere-derived cells was
assessed by immunofluorescence staining and western blot.
Results: NPC sphere-derived cells grown in serum-free non-adherent culture showed increased expression of stem
cell markers and EMT markers compared to parental cells grown in conventional culture. Although EGCG induced
growth inhibition and apoptosis in the parental cells in a dose-dependent manner, it was not as effective against
spheres. However, EGCG potently inhibited sphere formation and can eliminate the stem cell characteristics of NPC
and inhibit the epithelial-mesenchymal transition (EMT) signatures.
Conclusions: Overall, these findings show that NPC cells with sphere formations possess the properties of CSC.
Using this model, we found that EGCG regulated NPC CSC, their self-renewal capacity, and inhibited their invasive
characteristics. It supports the pivotal role of EGCG as a dietary compound targeting NPC and may decrease
recurrence and metastasis in nasopharyngeal carcinoma cells.
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Nasopharyngeal carcinoma (NPC) arises from the naso-
pharyngeal epithelial cells with high prevalent rates in
Southeast China and Taiwan. According to the World
Health Organization (WHO) histological classification,
NPC is categorized into three groups: keratinizing squa-
mous cell carcinoma (SCC, type I), nonkeratinizing car-
cinoma (NKC, type II) and undifferentiated carcinoma
(UC, type III) [1]. NPC has high metastatic potential
with frequent initial dissemination to regional lymph
nodes, and distant metastases at diagnosis, and this
underlies the majority of NPC-related death [2,3].
Advanced-stage NPC might have chemotherapy resist-
ance and radio-resistance. The prognosis remains poor
in a significant number of NPC patients with relapse or
metastatic diseases.
Evidences support the hypothesis that tumors contain
small subpopulations of cells called cancer stem-like cells
(CSC) or tumor-initiating cells (TIC) [4,5]. These cells
are generally thought of as self-renewing cells that are
able to reinitiate a tumor for several generations and can
give rise to a spectrum of differentiated cells. CSCs are
able to proliferate and self-renew extensively because of
their ability to express anti-apoptotic and drug-resistant
proteins, thus sustaining tumor growth [6]. Presumed
cancer stem-like cells had been proposed in nasopharyn-
geal tumors by side population and surface markers [7,8].
To eradicate NPC and prevent recurrence, it is impera-
tive that NPC CSC should be specifically and efficiently
inhibited. In addition, CSC undergoing metastasis often
expresses epithelial-to-mesenchymal transition (EMT)
and the high EMT markers have been observed in dis-
semination of carcinoma cells from primary epithelial
tumors [9]. The interaction between stemness character-
istics and EMT expression has advanced results in recent
studies. Researches have shown that EMT acquires CSC
properties, increases cancer cell tumorigenicity and
shows a crucial link to metastasis [10-12].
One assay for enriched and characterized stem cells is
based on the sphere-generated cells growing in serum
free suspension. These cells may represent a tumor-
initiating subpopulation with an ability of self-renewal,
and proliferate unlimitedly [13]. We demonstrated that
the sphere-derived cells of NPC are more invasive, che-
moresistant, and express anti-apoptosis and EMT genes
compared to parental monolayer cells and these served
as a model for designing experiments.
The cancer preventive effects of green tea are widely
supported by results from epidemiological, cell culture,
animal and clinical studies. This property has mainly
been attributed to the most prevalent tea polyphenol,
epigallocathechin gallate (EGCG), which has potent cap-
acity in inhibiting cancer growth and inducing apoptosis
in various cancers by several mechanisms. It causes cellcycle deregulation and apoptosis of cancer cells through
NF-kappa B inhibition and activation of caspases [14,15].
It inhibited expressions of Bcl-2 and Bcl-XL and induced
expressions of Bax, Bak and Bcl-XS [16,17]. In addition,
EGCG inhibited angiogenesis and metastasis through
repressing the expression of vascular endothelial growth
factor (VEGF), and matrix metalloproteinases (MMP)-2
and MMP-9 in prostate cancer [18]. It is also an import-
ant preventive agent for declining cancer incidence, and
has synergistic effects on cancer cell responses to con-
ventional chemotherapy [19-21].
Recent studies have shown that some dietary com-
pounds have potential to act against CSC through sev-
eral regulatory mechanisms [22-24]. However, EGCG
involved in possible mediated molecular mechanisms
and therapeutic targets in regulating CSC has been
largely unexplored.
This study investigated if EGCG can target NPC CSC




Parental monolayer cell culture
NPC TW01 (WHO type I, keratinizing squamous cell
carcinoma) and TW06 (WHO type III, undifferentiated
carcinoma) cell lines established from Taiwanese were
cultured in 10cm2 dishes with Dulbecco’s Modified
Eagle Medium (DMEM) (Invitrogen Carlsbad, CA) and
10% FBS (BIOIND, Kibbutz Beit Haemek, Israel), 1%
sodium pyruvate (BIOIND), 1% penicillin, streptomycin,
amphotericin (PSA, BIOIND) and 1% Non-Essential
Amino Acids (NEAA, BIOIND). The cells were incu-
bated at 37°C in a humidified atmosphere of 5% CO2.
Non-adherent culture
TW01 and TW06 parental cells were seeded non-
adhesively in 6-well culture dishes coated with thin agar-
ose at a density of 2 × 104/mm3 in serum-free DMEM/
F12 medium (Invitrogen). Each treatment was carried
out in triplicates. The culture medium was changed
every other day until sphere formation. After 7 to 10
days, the spheres were collected by filtration through a
70 μm mesh for the following experiments.
RNA extraction and quantitative real-time RT-PCR
The total RNA was isolated with Trizol reagent (Invitro-
gen). First-strand cDNA was reverse transcribed (RT)
according to the manufacturer protocols. Relative levels
of mRNA were determined by qPCR using a real time
PCR system. Several stemness genes and epithelial-
mesenchymal transition markers were analyzed. The pri-
mer sequences used for quantitative real-time RT-PCR
are shown in Table 1. GAPDH was the endogenous
Table 1 The primer sequences for q-RT PCR used in this
study
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94°C for 30 s, 55°C for 30 s, and 72°C for 45 s. q-PCR
was performed using an ABI PRISMW 7900HT system
(Applied Biosystems, Foster City, CA).Cell proliferation assay by MTT and BrdU assay
The effect of EGCG on proliferation of NPC TW01,
TW06 parental and sphere-derived cells was examined
by MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenylte-
trazolium bromide] assay. Cells (2.5 × 103 per well) were
seeded in 96-well plates and allowed to grow for 24 h.
Then EGCG or DMSO (vehicle control) was added after
plating onto adherent cells at specified concentrations.
Each treatment was triplicated. After 72 h, 20 μl of
MTT solution (5 mg/ml; Sigma, St. Louis, MO) was
added to each well and incubated for 4 h at 37°C. The
MTT formazan crystal was then dissolved in DMSO,
and the absorbance was measured by a microplate
reader (Bio-Rad 680, Bio-Rad Laboratories, Hercules,
CA) at a wavelength of 570 nm.
Cell proliferation was also determined by bromodeox-
yuridine (BrdU) incorporation analysis (Roche Applied
Science, Mannheim, Germany). Briefly, cells were plated
in 96-well plates (2.5 × 103 per well) for 24 h and BrdU
incorporated in the newly-synthesized DNA of EGCG-treated or vehicle was quantified after 72 h. After labeling
with BrdU (10 μM) for 2 h, cells were fixed, incubated
with anti-BrdU-peroxidase (10 μl/well) for 1 h and 30
min, and followed by the addition of trimethyl benzidine
substrate to measure the amount of incorporated BrdU.
Absorbance of each well was measured at wavelength of
450 nm.
Apoptosis assessed by flow cytometry
TW01 parental and sphere-derived cells were treated
after plating in the monolayer with different concentra-
tions of EGCG for 72 h respectively. Cells were washed
twice with cold PBS and then resuspended in 1X Bind-
ing Buffer at a concentration of 1 × 106 cells/ml. Trans-
fer of 100 μl of solution (1 × 105 cells) to a 5 ml culture
tube was performed and 5 μl of FITC Annexin V and
5 μl propidium iodide (PI) (BD Pharmingen, San Diego,
CA) were then added. The cells were gently vortexed,
and incubated for 15 min at RT (25°C) in the dark.
A 400 μl of 1X Binding Buffer was added to each
tube. Analysis was performed by FC500 flow cytometer
(Beckman Coulter, Brea CA) to identify the subpopula-
tions of the apoptosis cells within 1 hr.
Soft agar clonogeneic assay
The bottom of each well (35 mm) of 6-well culture dish
was coated with 2 ml agar mixture (DMEM, 10% [v/v]
FCS, 0.6% [w/v] agar). After the bottom layer solidified,
2 ml top agar-medium mixture (DMEM, 10% [v/v] FCS,
0.3% [w/v] agar) containing 2 × 104 sphere-derived cells
with different concentrations of EGCG was added and
incubated at 37°C for 2 weeks. At the end of the incuba-
tion period, the number of colonies was counted using
microscope after staining with the crystal violet.
Wound healing assay
NPC TW01 parental and sphere-derived cells were
seeded in 6-well plates and grown to confluence, and
then added with EGCG. Monolayers were scraped with
a micropipette and photographed at the beginning of the
assay at 0 h and at 24 h in respective conditions.
Cell invasion assay
CultrexW 96 Well Collagen IV Cell Invasion Assay
(Trevigen Inc. Gaithersburg, MD) was used according to
the manufacturer instructions. Briefly, cells were cultured
to 80% confluence, serum starved over-night, then har-
vested and re-suspended to a density of 5 × 104 cells/ml
in serum-free medium. Cell suspension of 50 μl was
added to the top chamber with and without EGCG, and
150 μl of media with FBS was added to the lower well.
The top invasion chamber was coated with a membrane
of 50 μl BME (basement membrane extract) solution.
The chambers were incubated at 37°C in a humidified
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the lower wells were detected by calcein-AM staining
followed by fluorescence measurement on a microplate
reader at 485 nm excitation and 520 nm emissions.Immunofluorescence staining
Cells were cultured on sterile glass coverslips in 6-well
plates and fixed in 4% paraformaldehyde. After washing
with PBS, the cells were permeabilized using 0.1% Triton
X-100 solution and blocked with 10% BSA. The slides
were incubated overnight at 4°C with the primary anti-
bodies, followed by incubation with the fluorescently-
labeled secondary antibodies at room temperature for
1 h. Slides were counterstained with 40-6-diamidino-2-A 
B 
C 
Figure 1 NPC sphered cells showed different properties compared to
non-adherent condition (B) Different cell shape of TW01 parental and sphe
for 48 h. Sphered cells present in mesenchymal shape. (C) Sphere-derived
(Scale bars show 100 μm).phenylindole (DAPI) and analyzed under a fluorescent
microscope (Leica DM 4000B).
Western blot analysis
Western blot was performed to detect proteins involved
in EMT (E-cadherin, Snail, and Vimentin). Cells were
lysed in a RIPA buffer containing a 1X protease inhibitor
cocktail, and protein concentrations were determined
using the Bradford assay (Bio-Rad, Philadelphia, PA).
Proteins were separated by 10%-12.5% SDS/PAGE and
transferred to membranes (Millipore, Bedford, MA) at
55 V for 4 h at 4°C. After blocking in 5% non-fat dry
milk in TBS, the membranes were incubated with
primary antibodies at 1:1000 dilution in TBS overnight
at 4°C, washed 3 times with TBS-Tween 20, and thenparental cells. (A) NPC TW01 sphere grew in serum free
re-derived cells were noted when cultured adherently in 10% serum
cells present more powerful migratory behavior after 12 h of scraping
Figure 2 mRNA expressions of stemness genes and EMT markers analyzed by q-RT-PCR. The amounts of Sox-2, Oct-4, Klf-4 and EMT
markers Vimetin, Twist, Snail and N-cad were increased in TW01 sphere-derived cells as compared to parental cells. The internal control is
housekeeping gene-GAPDH and every gene expression of sphere-derived cells was normalized with parental cells. Data represent mean ± SD.
* means significantly different from respective controls, p < 0.05.
Figure 3 Effect of EGCG on NPC cell proliferation. EGCG had effects on cell proliferation and induced growth inhibition of NPC parental and
sphere-derived cell in a concentration dependent manner. However, sphere-derived cells showed relative resistance to EGCG (μM) compared to
parental cells. (A) MTT assay and (B) BrdU assay. Both assays showed similar results.
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Figure 4 Apoptosis effect of EGCG on NPC cells. The upper panel shows the apoptosis frequency of TW01 parental cell increased from 4.3%
up to 63.6% after 40μM EGCG treatment, while only up to 12.7% is noted in the sphere-derived cells. The lower panel shows EGCG-induced
TW01 parental cell apoptosis was significantly correlated with a dose-dependent trend but was not as effective in TW01 sphere-derived cells.
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horseradish peroxidase at 1:5000 dilution in TBS for
1 h at room temperature. Membranes were washed
again in TBS-Tween 20 3 times at room temperature.
Protein bands were visualized on X-ray film using an
enhanced chemiluminescence detection system. The
primary antibodies against E-cadherin and Vimentin
were purchased from Sigma-Aldrich (St Louis, MO).
Snail from Abcam (Cambridge, MA) and used at a di-
lution of 1:1000.Statistical analysis
Data are expressed as the mean ± SD from a minimum
of 3 separate experiments. The differences between 2
groups were analyzed by the Student t-test. The differ-
ences among 3 groups were analyzed by one or two way
ANOVA, statistical significance was considered as
p<0.05. Statistical analyses were performed with SPSS
for Windows version 14.0.
We had ethical approval. Our experimental research
performed with the approval of an appropriate ethics
Figure 5 Inhibition of colony formation of EGCG in a
dose-dependent manner. Both TW01 and TW06 sphere-derived
cells were treated with 20 μM or 40 μM EGCG and performed
colony formation assay. Decreasing colony number are noted when
EGCG concentration increasing. Data represent mean ± SD. * or
# means significantly different from respective controls, p < 0.05.
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humans and not on animals.
Results
NPC Cells with ability to form spheres acquired features
of CSC and underwent EMT
First, we investigated NPC cell lines containing cells
with self-renewal that form tumor spheres, and have the
ability to migrate, invade, and express the EMT pheno-
type (Figure 1). NPC cells showed increased expression
of stem cell markers Sox-2, Oct-4, and Klf-4 in sphere-
derived cells grown in serum-free non-adherent culture
compared to parental cells grown in conventional cul-
ture. In addition, the expression of mRNA of the tran-
scription factors involved in EMT, such as Twist, Snail,
and mesenchymal makers, such as Vimetin and N-
cadherin were also increased in sphere-derived cells
compared to the parental cells. However, a decreased ex-
pression of E-cadherin in sphere-derived cells was
detected (Figure 2).
Effects of EGCG on TW01, TW06 growth, and apoptosis
The proliferation-inhibition effects of EGCG with differ-
ent concentrations in NPC TW01 and TW06 cell lines
were evaluated by MTT assay and BrdU assay. Both
results showed EGCG-induced inhibition of TW01 and
TW06 proliferation in a concentration dependent man-
ner (Figure 3). However, sphere-derived cells showed
more resistance to the EGCG-inhibition effect compared
to parental cells, and were less effective in inducing
growth inhibition.
The apoptosis effect modulated by EGCG was
detected by flow cytometry with Annexin V and PI
double staining. The results showed increased apoptotic
activity in TW01 parental cells treated with 40 μM
EGCG for 72 h but this was not apparent in TW01
sphere-derived cells (Figure 4). As compared to the con-
trol, EGCG-induced TW01 parental cell apoptosis sig-
nificantly correlated to dose-dependent trends, however,
this did not occur in TW01 sphere-derived cells.
Inhibition on NPC sphere-derived cell colony formation,
migration, and invasion by EGCG
TW01 and TW06 sphere-derived cells were grown in agar
and various doses of EGCG were added for 2 weeks. Col-
onies were counted at the end of the incubation period,
and we found that EGCG inhibited the growth of colonies
in a dose-dependent manner (Figure 5). The results sug-
gest that EGCG can inhibit the self-renewal and tumori-
genicity capacity of NPC CSC.
Wound-healing assay was performed to assess whether
EGCG affected TW01 sphere-derived cell migration.
The control group without EGCG treatment produced
marked cell migration in the wound area 24 hr afterwounding, but wounds treated with EGCG showed sig-
nificant delays under the same conditions (Figure 6). By
the cell invasion assay, the invasive ability was signifi-
cantly inhibited in sphere-derived cells treated with
EGCG in a dose-dependent manner (Figure 7).EGCG regulated the expression of stem cell genes in
sphere-derived cells
Increased expression of stemness genes–Sox-2, Klf-4,
and Oct-4 was detected in sphere-derived cells com-
pared to parental cells. We next examined the effects
of EGCG on the mRNA expression levels of these
factors. TW01 sphere-derived cells were treated with or
without EGCG. After a 36 h incubation period, cells were
harvested and the expression of Sox-2, Klf-4, and Oct-4
was measured by the real-time RT-PCR (Figure 8). The
results showed EGCG inhibited the expression of Klf-4
and Oct-4 in sphere-derived cells. However, the expres-
sion of Sox-2 was not affected by EGCG.
Figure 6 EGCG inhibited cell migration shown by wound healing assay. TW01 sphere-derived cells produced marked cell migration in the
wound area 24 h after wounding, but wounds treated with EGCG showed significant delays under the same conditions.
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Due to change of cell shape and EMT marker expres-
sion, NPC sphered cells might have undergone EMT
change. We then studied whether the expression of
EMT markers regulated by EGCG in TW01 sphere-
derived cells correlated with migration and invasive
property changes. Immunofluorescence staining in
sphere-derived cells treated with or without EGCG was
performed and showed that vimentin expression was
decreased in EGCG-treated cells (Figure 9A~C). More-
over, in western blotting, EGCG significantly inhibited
the levels of Snail, Vimentin and increased E-Cadherin
expression in a dose-dependent manner (Figure 9D).
Our results showed that the invasion and migration abil-
ity of TW01 sphere-derived cells was inhibited by EGCG
in relation to regulating EMT-related protein expression.
Discussion
Unlimited growth, recurrence, and metastasis of cancer
have been related to the behavior of CSC that can be
identified by in vitro assay. Cancer stem cells undergoing
metastasis that have been demonstrated to have EMT
marker expressions associated with invasive and migra-
tory properties easily invade the surrounding tissues.
This invasive type of cancer cell acquired mesenchymal,
fibroblast-like morphology and shows reduced intercellu-
lar adhesion and increased motility [12]. Tumor progres-
sion is frequently associated with the down-regulation of
E-cadherin, and up-regulation of vimentin, and several
transcription factors including Snail, Twist and Slug
[12,25]. A major clinical feature of NPC is frequent in-
volvement of regional lymph nodes and distant organmetastasis. Even after treatment, increased invasiveness
and migration of NPC during metastasis leads to poor
outcomes and increased patient mortality [26]. Previous
studies showed EMT molecular events associated with
NPC metastasis were obvious in the absence of the
Epstein-Barr virus genome [27].
The isolation of CSC from cancer cells was achieved
successfully using several techniques. CSC can be
enriched in spheres cultured in serum-free mediums
supplemented with mitogens, such as the basic fibroblast
growth factor (bFGF) and epidermal growth factor
(EGF) [13,28,29]. Such cancer cells grown in a sus-
pended condition exhibit resistance to anoikis, resulting
in acquisition of ability to survive and proliferate [30].
We quantified and enriched CSC within NPC cell lines
and subsequently characterized their phenotypical and
functional properties, such as invasion capacity and
epithelial-mesenchymal transition (EMT). These spheres
contain putative CSC and can provide niches for the
maintenance and growth of cancer cells. The EMT-type
cells share many biological characteristics of CSC, which
are linked closely with tumor recurrence and metastasis.
Previous studies exploited EGCG as a potential agent
for prevention and treatment of cancers. EGCG sup-
presses the expression of HSP70 and HSP90, and exhibits
anti-tumor activity in vitro and in vivo [31]. Moreover, in
addition to EGCG-induced apoptosis effects, previous
researches have recognized that EGCG-induced p21, p53,
p16, and p27 expression, which is associated with nega-
tive regulations of cell cycle progression [32-34]. How-
ever, there were limited reports about EGCG regulation
effects on CSC. Our study proposes phenotype changes
Figure 7 Inhibition of cell invasion of EGCG in a dose-
dependent manner. EGCG inhibits invasion abilities of NPC
sphere-derived cells. (A) TW01 sphere-derived cells, (B) TW06
sphere-derived cells. Data represent mean ± SD. * or # were
significantly different from respective controls, p < 0.05.
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effects of EGCG on CSC properties of NPC are seen.
Our designed experiments recognized the effects of
EGCG on isolated sphere cells with anchorage-
independent growth, and obtained novel findings. We
discovered EGCG inhibits growth and induces apoptosisFigure 8 Expression of stemness genes was blocked by EGCG. The exp
cells treated with EGCG was measured by the q-RT-PCR. Decreasing expres
represented mean ± SD. * or # means significantly different from respectivin parental NPC cells, but is inefficient in sphere-derived
cells. Relative chemo-resistant NPC cells in sphere-
derived cells, in accordance to Chen’s study on non-
adhesive culture systems exhibiting CSC characteristics,
can be used in cancer research [35].
On the other hand, EGCG can inhibit sphere forma-
tion and regulate invasive-like phenotypes characterized
by EMT of cells grown in serum free non-adherent cul-
tures. In addition, it inhibited colony formation of
sphere-derived cells grown in agar in a dose-dependent
manner. This implicated that EGCG can be effective in
suppressing the self-renewal capacity of NPC CSC. Fur-
thermore, at the mRNA level, the expression of stemness
maintaining transcription factors Klf-4 and Oct-4 were
inhibited by EGCG. Several studies suggested Klf-4 and
Oct-4 play important roles in maintaining stem cell
identity, and are responsible for increased cell migration
and invasion [36,37]. Our study further showed that
EGCG inhibits the factors required for maintaining the
self-renewal capacity in NPC CSC.
Because CSCs appear to have a significant role in inva-
sion and metastasis, we measured the effects of EGCG
on invasion and migration of NPC sphere-derived cells.
The results showed that invasive and migratory beha-
viors were significantly reduced in the EGCG-treated
group in a dose-dependent manner. This implied EGCG
efficiently suppressed the metastasis ability in NPC CSC.
Recent studies have also described the inhibitory activ-
ities of EGCG targeting cancer stem cells, which can
suppress CSC self-renewal properties and block their
migration and invasion [38,39].
Enhanced EMT characteristics are associated with
poor outcomes and declined survival in patients with
NPC [40]. We examined EGCG regulating transla-
tional levels of EMT expression by TW01 sphere-
derived cells. The western blot result showed EGCG
inhibits the expression of vimentin, Snail, and is ac-
companied by the upregulation of E-cadherin. Im-
munofluorescence staining showed that vimentin
expression in sphere-derived cells was decreased inression of stem cell genes (Oct4, Sox2, Klf4) of TW01 sphere-derived
sion of OCT4 and Klf4 was accompanied with EGCG dosage. Data is







Figure 9 Effect of EGCG on EMT phenotype. Mesenchymal cell
marker, vimentin expression was assayed by immunofluorescence
staining in TW01 sphere-derived cells (A~C). (A) control group (B)
treated with 20 μM EGCG (C) treated with 40 μM EGCG. EGCG could
decrease the expression of vimentin. Green fluorescent signal
represents vimentin expression. Blue color is DAPI stain for nucleus.
(D) Western blot signals in TW01 sphere-derived cells show
decreased expression of vimentin and snail and increased expression
of E-cadh (e-cadherin) after EGCG treatment.
Lin et al. BMC Complementary and Alternative Medicine 2012, 12:201 Page 10 of 12
http://www.biomedcentral.com/1472-6882/12/201the EGCG group compared to the control group.
These results showed that EGCG may block NPC
early metastasis signaling. Dysregulation of E-cadherin
and β-catenin functions in cell-cell adhesion is com-
mon in NPC, and correlates with advanced stage dis-
ease and lymph node metastasis [41]. Our results
further showed that EGCG inhibited NPC invasion
and migration, correlating with the elevation of E-
cadherin levels in NPC sphere-derived cells. E-cadherin is
an important cell adhesion molecule, and has a key role in
the early stage of tumor metastasis. Further investigation
is required to study how EGCG modulates the expression
of E-cadherin proteins.
Research regarding the use of EGCG against cancer
has been proposed, however, most concentrations of
EGCG used in cell lines are higher than the plasma con-
centrations observed in people after consuming tea be-
cause of its limited bioavailability in vivo [42]. To
increase bioavailability and stability of EGCG, particular
studies have elucidated structure-modified compounds
with higher efficacy, which also possess anticancer activ-
ities [39,43]. Previous research has shown evidence of
EGCG-induced apoptosis and cytotoxicity specifically on
cancer cells, but not on normal cells under the same
EGCG treatment [44,45]. This suggests that EGCG
serves as an acceptable safety agent.
Overall, our findings further clarify the anti-cancer
effects of EGCG, which can eliminate the stem-cell char-
acteristics of NPC, and inhibit epithelial-mesenchymal
transition (EMT), partially because of regulated EMT-
related proteins and lessen the migratory and invasive
abilities of NPC. EGCG may be potentially effective in
preventing the recurrence and metastasis of NPC in
combination with standard treatment.Conclusions
Our data shows that NPC cells with sphere formations
possess the properties of CSC including EMT signatures,
and their self-renewal capacities and invasive character-
istics are inhibited by EGCG. This data supports the piv-
otal role of EGCG as a dietary compound targeting
NPC, and may decrease recurrence and metastasis in
nasopharyngeal carcinoma cells.
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